线粒体靶向药物衍生工具揭示线粒体DNA损伤如何触发气道上皮细胞的先天免疫信号
Understanding how inflammation begins so scientists can end it
UCR团队开发的线粒体靶向氯苯丁酸酯衍生物可在气道上皮细胞中特异性损伤线粒体DNA而不影响核DNA,驱动线粒体核酸释放并激活先天免疫炎症信号。较低剂量下线粒体仍可正常耗氧,较高剂量则造成广泛DNA损伤且线粒体行为异常。该工具发表于Free Radical Biology and Medicine,目前仅为体外研究。
Chronic inflammation is a major factor in arthritis, type 2 diabetes, Alzheimer's disease and cancer. A new tool developed at UC Riverside allows researchers to see exactly how inflammation begins in human cells. In their study published in Free Radical Biology and Medicine, researchers used cells lining the airways, as these come into direct contact with inhaled, inflammation-triggering pollutants. Learning what sets off this inflammation on a cellular level could eventually help researchers find ways to stop it from becoming chronic.
The study specifically focused on damage to DNA in mitochondria, the structures that supply much of a cell's energy. Mitochondria carry their own DNA, which is separate from DNA that resides in the cell nucleus.
Earlier research has shown that mitochondrial DNA is key to the immune response. But many chemicals damage DNA in both the mitochondria and the nucleus, making it hard to tell what role each might play in triggering the body's responses.
"This tool gives us a new way to investigate how mitochondrial injury contributes to inflammation," said UCR chemistry professor and the study's corresponding author Linlin Zhao.
Some pollutants and medicines can cause damage by leaving small groups of chemicals attached to DNA building blocks. This kind of damage, called alkylation, can also come from ordinary, natural chemical reactions inside cells. The researchers wanted to know whether alkylation could set off inflammation when it occurs in the mitochondria.
To find out, postdoctoral researcher Anal Jana started with chlorambucil, a chemotherapy drug that can damage DNA. He added a chemical group that helps the drug collect in mitochondria. "I designed the molecule by combining my expertise in chemical synthesis with the Zhao lab's extensive experience in mitochondrial biology," Jana said.
Graduate student Anthony Rios, the first author of the study, tested this modified version as a tool to damage mitochondrial DNA in lab-grown human airway cells. Though the tool did not damage DNA from the nucleus, researchers noticed damaged mitochondrial DNA in the fluid outside the mitochondria. In this part of the cell, these damaged molecules can signal injury and activate genes involved in immune response and inflammation.
The amount of damage from Jana's tool mattered. At a lower dose, the researchers could detect changes to mitochondrial DNA while the mitochondria still behaved somewhat normally, consuming oxygen at their usual rate. At the higher dose, the DNA damage from the tool was more extensive, and the mitochondria behaved abnormally.
Zhao's team plans to test versions of the molecule that cause different amounts of DNA damage. The goal is to find out precisely how much damage it takes to set off inflammatory signals, whether the same process plays a role as cells age and whether aging cells respond differently.
Identifying what sets inflammation in motion could eventually help scientists pinpoint where to intervene before the response persists long enough to contribute to disease. One question is which damage-related molecules that appeared outside the mitochondria helped trigger the response.
"If we can figure out which steps set inflammation in motion, we can start looking for ways to intervene before it becomes chronic," Zhao said.
Publication details
Anthony Rios et al., Mitochondria-Targeted Chlorambucil Derivative Drives Mitochondrial Nucleic-Acid Output and Innate Immune Signaling, Free Radical Biology and Medicine (2026). DOI: 10.1016/j.freeradbiomed.2026.11.018
Journal information: Free Radical Biology and Medicine
Key medical concepts
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Understanding how inflammation begins so scientists can end it (2026, November 17) retrieved 17 November 2026 from https://medicalxpress.com/news/2026-11-inflammation-scientists.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com